Keyphrases
Atopic Dermatitis
100%
Large Colonies
100%
Lancefield Group A
100%
Staphylococcus Aureus Colonization
100%
Prospective Birth Cohort
100%
Cheek
100%
Matrix-assisted Laser Desorption Ionization-time of Flight Mass Spectrometry (MALDI-TOF MS)
100%
β-hemolytic Streptococci
100%
Mass Spectrometry Identification
100%
Streptococcus Dysgalactiae
57%
Streptococcus Pyogenes (S. pyogenes)
57%
S. Aureus Colonization
55%
S. Canis
28%
Species Level
28%
Staphylococcus Aureus
22%
Streptococcus Equi
14%
Reference Spectra
14%
16S rRNA Sequencing
14%
Streptococcus Canis
14%
Extraction Protocol
14%
Direct Method
14%
Identification Rate
14%
MALDI-TOF
14%
Phenotypic Characteristics
14%
Mass Spectrometry Analysis
14%
From below
14%
Blood Culture
14%
Two-stage Approach
14%
Mass Spectrometry Data
14%
Confidence Interval
11%
Etiopathogenesis
11%
Adjusted Hazard Ratio
11%
Immune Function
11%
Skin Barrier
11%
At Birth
11%
Age of Onset
11%
Filaggrin Gene mutation
11%
Mutation Status
11%
Barrier Impairment
11%
Severity of Atopic Dermatitis
11%
Early Infancy
11%
Parental Atopy
11%
Antibiotic Use
11%
Immunology and Microbiology
Matrix-Assisted Laser Desorption-Ionization
100%
Time-of-Flight Mass Spectrometry
100%
Beta Hemolytic Streptococcus
100%
Staphylococcus Aureus
100%
Cheek
100%
Atopic Dermatitis
100%
Streptococcus pyogenes
50%
Canis
25%
Mass Spectrometry
12%
Streptococcus canis
12%
Streptococcus Dysgalactiae
12%
Equus
12%
Infancy
10%
Gene Mutation
10%
Atopy
10%
Prevalence
10%
Pharmacology, Toxicology and Pharmaceutical Science
Staphylococcus Aureus
100%
Atopic Dermatitis
100%
Beta Hemolytic Streptococcus
100%
Matrix-Assisted Laser Desorption/Ionization
100%
Streptococcus pyogenes
57%
Canis
28%
Streptococcus canis
14%
RNA 16S
14%
Streptococcus Dysgalactiae
14%
Equus
14%
Filaggrin
10%
Prevalence
10%
Emollient Agent
10%
Antibiotic Agent
10%
Etiology
10%
Cohort Study
10%
Onset Age
10%
Atopy
10%
